// App-Quantinova.ai

TP404 : Applying ARISTOTLE Trial to Actual Practice

Researchers

Presenter

  • Michael Stokes

Principal Investigators

  • Ning Wu

  • Elyse Gatt

  • Dinara Makenbaeva

  • Daniel Wiederkehr

  • Luke Boulanger

Medical Centers

  • University California, Irvine, Irvine, CA

  • United BioSource Corporation, Lexington, MA

  • al, QC, Canada

Locations

  • United States

  • Canada

Companies

  • Pfizer Inc.

  • Bristol-Myers Squibb

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Non-valvular atrial fibrillation

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • apixaban

  • Warfarin

Outcome

  • N/A


Study Design

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim